CAS 1005201-24-0
:Fórmula:C18H14N2O3S
InChI:InChI=1S/C18H14N2O3S/c1-11-19-20-18(23-11)13-5-8-17-15(9-13)16(10-22-17)12-3-6-14(7-4-12)24(2)21/h3-10H,1-2H3
Clave InChI:RCKYSTKYIVULEK-UHFFFAOYSA-N
SMILES:CC1=NN=C(O1)C2=CC3=C(C=C2)OC=C3C4=CC=C(C=C4)S(=O)C
Filtrar por
Porcentaje de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Se han encontrado 7 productos.
- Precio más bajo
- Precio más alto
- Pureza más baja
- Pureza más alta
- Entrega estimada más rápida
2-Methyl-5-(3-(4-(methylsulfinyl)phenyl)benzofuran-5-yl)-1,3,4-oxadiazole
CAS:2-Methyl-5-(3-(4-(methylsulfinyl)phenyl)benzofuran-5-yl)-1,3,4-oxadiazoleFórmula:C18H14N2O3SPureza:95%Peso molecular:338.382-Methyl-5-(3-(4-(methylsulfinyl)phenyl)benzofuran-5-yl)-1,3,4-oxadiazole
CAS:2-Methyl-5-(3-(4-(methylsulfinyl)phenyl)benzofuran-5-yl)-1,3,4-oxadiazoleFórmula:C18H14N2O3SPureza:99%Peso molecular:338.3882-Methyl-5-(3-(4-(methylsulfinyl)phenyl)benzofuran-5-yl)-1,3,4-oxadiazole
CAS:Fórmula:C18H14N2O3SPureza:99%Peso molecular:338.38GSK-3² Inhibitor XXIV
CAS:GSK-3² Inhibitor XXIV is a compound that inhibits the activity of glycogen synthase kinase-3, an enzyme that controls the synthesis of glycogen in the liver. It has been shown to have effects on cell maturation and pluripotent stem cells. GSK-3² Inhibitor XXIV has also been seen to have protective effects against hematopoietic cells. This compound can be used to treat Alzheimer's disease and other diseases that are caused by an accumulation of protein aggregates such as intestinal disorders. GSK-3² Inhibitor XXIV is also not toxic to healthy cells and does not cause any adverse side effects.Fórmula:C18H14N2O3SPureza:Min. 95%Peso molecular:338.38 g/molTCS 2002
CAS:GSK-3β inhibitor 9b: potent, selective, oral, IC50=35 nM, good pharmacokinetics, BBB-permeable, researched for Alzheimer's.Fórmula:C18H14N2O3SForma y color:SolidPeso molecular:338.38
